Article
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Hepatology (Baltimore, Md.) - 1 Jun 2013
Yu Ming-Lung, Lee Chuan-Mo, Chen Chi-Ling, Chuang Wan-Long, Lu Sheng-Nan, Liu Chen-Hua, Wu Shun-Sheng, Liao Li-Ying, Kuo Hsing-Tao, Chao You-Chen, Tung Shui-Yi, Yang Sien-Sing, Kao Jia-Horng, Su Wei-Wen, Lin Chih-Lin, Yang Hung-Chih, Chen Pei-Jer, Chen Ding-Shinn, Liu Chun-Jen
Abstract excerpt
UNLABELLED: Patients dually infected with hepatitis C virus (HCV)/hepatitis B virus (HBV) have a higher risk of developing advanced liver disease or hepatocellular carcinoma compared with monoinfected patients. Yet, there is a similar rate of sustained virologic response (SVR) after peginterferon alfa-2a and ribavirin combination therapy in these patients compared with HCV-monoinfected patients and a high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.